Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results
about
Surveillance of gastric intestinal metaplasia for the prevention of gastric cancerHelicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillanceHelicobacter pylori in humans: Where are we now?Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuHelicobacter pylori eradication for preventing gastric cancerConsensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancerManagement of Helicobacter pylori infection in Latin America: a Delphi technique-based consensusMicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cellsUsing stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration.Screening for and surveillance of gastric cancer.Epidemiological review of gastric cancer in India.Helicobacter pylori in First Nations and recent immigrant populations in Canada.Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity.Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical ConsiderationsHelicobacter Pylori and Gastric Cancer: Clinical Aspects.The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communitiesGastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection.Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.Biomarkers of Helicobacter pylori-associated gastric cancer.Acetaldehyde and gastric cancer.Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed?Review article: the epidemiology and prevention of gastric cancer.Population screening and treatment of Helicobacter pylori infection.H. pylori Management in ASEAN: the Bangkok Consensus Report.Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug
P2860
Q24198037-4CEAF88D-5341-4052-B431-FDEAAB57810AQ26774447-885119E6-E8AF-476A-92AE-502E7AB9D162Q26825856-3027AC87-5A3E-427D-A659-E65DEEEC69A5Q30244173-E7CF8DD1-C2D2-4C94-845B-C3A7D5C1A3B7Q30426539-F13753B2-A8E4-47FA-AAE3-DE3E00F4B18CQ33626785-81ED8376-1F23-4153-8F2C-C57C814ABDAFQ33698340-FF3BA570-EDB9-45D2-8161-B25EC6279974Q33825711-BB2E2409-463B-4EE4-9E61-3DCFA2D0EBE4Q34067951-156F5186-51F2-49BE-A7E4-AEB4EE919CA9Q34247140-91BA71E5-FCDF-4A0C-9619-7DBAFB620A61Q34277478-53CD384A-8545-4573-99C7-F1CCFF055A1AQ34326563-274B12F6-584E-4D35-A8F9-5E44C2F07CB4Q35073308-D47BAC11-6ACC-40E0-B553-B73A50D1338FQ35744635-E7C1459B-A4C0-4027-9852-A9622AB4A3C4Q35755917-A75BB6EC-3994-4E4A-8AFD-A459F254390EQ36285479-79CDD768-C3EB-4CFC-8102-85B293169CE3Q36412858-F103F3F8-ABA6-4A59-B1AF-B90BC29C0DBAQ36695975-F19A0ACE-CFD3-45B6-B79A-3FD583B00ADEQ36745832-A6172C61-0F5D-448E-9EC4-434E942BA6DFQ36972107-449B1573-4765-4711-A17A-EEC46322E7DDQ37247773-A4F5D853-D5F2-4FE5-A0E4-22FCFE5C6CC0Q37433766-B899C118-A6B1-4F3F-8766-E07099D6AF82Q37591506-09DB8A3C-518D-4DF9-B703-E740B2F0EF0AQ37852813-2E5585C2-211B-4935-9296-0DC7F77F3889Q38097128-A0F9168E-061D-4B0C-98C7-EF5D7EBA89F5Q38150281-7E146C47-2ACC-4F43-AA56-B6F00B17F6A7Q38218870-D9FB2CF5-B480-4B01-AC2D-5F7F155288C1Q39067619-C27836E4-12EC-4AC1-A823-EC3EC2CBCCFEQ40100019-7916344F-43BA-4E00-B5BC-8D318A1A7E7DQ51215133-BE412FBD-55EA-4C5D-AF1F-7EA24FDF46EFQ57698678-533462AC-8C5A-4B73-81E6-CFC432AD60A6
P2860
Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exploring the cost-effectivene ...... tion of clinical trial results
@en
Exploring the cost-effectivene ...... ion of clinical trial results.
@nl
type
label
Exploring the cost-effectivene ...... tion of clinical trial results
@en
Exploring the cost-effectivene ...... ion of clinical trial results.
@nl
prefLabel
Exploring the cost-effectivene ...... tion of clinical trial results
@en
Exploring the cost-effectivene ...... ion of clinical trial results.
@nl
P2860
P356
P1476
Exploring the cost-effectivene ...... tion of clinical trial results
@en
P2093
Jennifer M Yeh
Karen M Kuntz
P2860
P304
P356
10.1002/IJC.23864
P577
2009-01-01T00:00:00Z